Compassionate use of tempol for recurrent prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial is a compassionate-use program for a single patient with prostate cancer that has returned after initial treatment. It provides access to an experimental drug called MBM-02 (tempol), which is not yet approved, when other options are limited.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that has returned, shown by a rise in PSA (a blood test marker).
- This is a single-patient program, not a regular clinical trial with many participants.
- You would receive the study drug MBM-02 (also called tempol), an investigational medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the blood pressure medication telmisartan in men with prostate cancer who are already on a stable treatment and not needing an immediate change. The goal is to see if adding telmisartan can help control the cancer without extra side effects.
This trial tests a drug called tarlatamab for people with advanced prostate cancer that has a specific protein (DLL3) on their tumor cells. The goal is to see if tarlatamab can help shrink or slow the cancer.
This study tests a new combination therapy for advanced prostate cancer that has stopped responding to standard treatments. It aims to see if the combination is more effective than placebo in slowing the cancer's growth.
This trial tests a new combination of two drugs (valemetostat and darolutamide) for men with metastatic castration-resistant prostate cancer that has worsened after prior treatment. The goal is to see if the combination can slow cancer growth.
This early-phase trial tests a new study drug called ACE-232 for men with advanced prostate cancer that has stopped responding to standard hormone therapy and chemotherapy. It aims to see if the drug is safe and may help slow the cancer.
This trial is for people with advanced cancer that has spread and is considered terminal. It aims to test a new treatment to see if it can help people in this situation.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.